BROWNSTEIN HYATT FARBER SCHRECK, LLP for JOHNSON & JOHNSON SERVICES, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2020 | $80,000 | Replaced |
| 1st Quarter - Amendment | Jul 8, 2020 | $80,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to corporate tax issues; Implementation of H.R. 1 (Tax Cuts and Jobs Act of 2017)
| Lobbyist | Covered position, as disclosed |
|---|---|
| RUSSELL W. SULLIVAN | — |
Health Issues HCR
Issues related to patient access S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
| Lobbyist | Covered position, as disclosed |
|---|---|
| NADEAM ELSHAMI | — |
| EMILY FELDER | — |
| MARC LAMPKIN | — |
| ELIZABETH ANNE MAIER | — |
| WILLIAM MOSCHELLA | — |
| ALFRED MOTTUR | — |
| JEROME MURRAY | — |
| ZACHARY PFISTER | — |
| BRIAN WILD | — |
Torts TOR
Issues related to civil justice reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM MOSCHELLA | — |
Consumer Issues/Safety/Products CSP
Issues related to pseudoephedrine Issues related to the regulation of cosmetic products Safe use of OTC products Matters related to American Medical Association Resolution 208(A-16) adopted April 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM MOSCHELLA | — |
| ALFRED MOTTUR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.